Letter to the Editor: In Vitro Activity of Oxazolidinone Against Nontuberculous Mycobacteria in China

Microb Drug Resist. 2023 Mar;29(3):112-114. doi: 10.1089/mdr.2022.0216. Epub 2023 Jan 10.

¹ Laboratory of Respiratory Diseases, Beijing Key Laboratory of Pediatric Respiratory Infection Diseases, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Key Laboratory of Major Diseases in Children, Ministry of Education, National Clinical Research Center for Respiratory Diseases, National Center for Children's Health, Beijing, China.
² National Tuberculosis Reference Laboratory, Chinese Center for Disease Control and Prevention, Beijing, China.
³ Institute for Immunization and Prevention, Beijing Center for Disease Control and Prevention, Beijing Academy for Preventive Medicine, Beijing Institute of Tuberculosis Control, Beijing, China.

No abstract available

MeSH terms